Welcome to our dedicated page for Precision Optics Corporation news (Ticker: $POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Precision Optics Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Precision Optics Corporation's position in the market.
Precision Optics , Inc. (NASDAQ: POCI) announced a record $9 million production order for single-use endoscope assemblies for cystoscopy surgery. This order highlights the company's technological capabilities and growth potential in the single-use medical device market. The order is expected to generate approximately $2.2 million in revenue by June 2025, $4.6 million in fiscal 2026, and the remainder by the first half of fiscal 2027.
Precision Optics , Inc. (Nasdaq: POCI) has scheduled a conference call to discuss third quarter fiscal year 2024 financial results on May 15, 2024. The Company will release its financial results and file its 10-Q after the market closes on the same day. Interested parties can access the call via phone or webcast.